Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (1 active)

Company-led only

7 records in Main database · 4 strong · 5 status checked

Compare	Program	Company / Sponsor	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	Otarmeni by Regeneron	Regeneron Pharmaceuticals	Therapeutic	-	Gene Therapy	Approved	Approved	Details checkedStrong evidence	regulatory · Priority 1	99%	PediatricAdult+6	Hearing LossSensorineural Hearing Loss+3
Add	AK-OTOF by Eli Lilly and Akouos	Eli Lilly and Company	Therapeutic	-	Gene Therapy	Phase 2	Active	Details checkedStrong evidence	trial · Priority 1	95%	PediatricAdult+6	Hearing LossSensorineural Hearing Loss+3
Add	SENS-501 by Sensorion	Sensorion	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 1	94%	PediatricCongenital+5	Hearing LossSensorineural Hearing Loss+3
Add	GJB2-GT by Sensorion	Sensorion	Therapeutic	-	Gene Therapy	Preclinical	Active	Details checkedStrong evidence	company · Priority 2	88%	CongenitalGenetic+1	Hearing LossSensorineural Hearing Loss+1
Add	OTO-825 by Otonomy	Otonomy	Therapeutic	-	Gene Therapy	Preclinical	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	87%	PediatricCongenital+2	Hearing LossSensorineural Hearing Loss+1
Add	EHT102 by EuHearing	Shanghai EuHearing Therapeutics Co., Ltd	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedClinical trial listing only	trial · Priority 2	90%	PediatricGenetic+3	Hearing LossSensorineural Hearing Loss+3
Add	OTOV101N + OTOV101C by OtoVia Therapeutics	OtoVia Therapeutics	Therapeutic	-	Gene Therapy	Interventional/NA	Unknown	Details checkedClinical trial listing only	registry+publication · Priority 2	86%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+2